Welcome to LookChem.com Sign In|Join Free

CAS

  • or

7413-36-7

Post Buying Request

7413-36-7 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

7413-36-7 Usage

Description

Nifenalol is a pharmaceutical compound that belongs to the class of beta adrenergic antagonists, also known as beta-blockers. It is characterized by its ability to block the action of adrenaline and noradrenaline on beta-adrenergic receptors, which plays a crucial role in the treatment of various medical conditions.

Uses

Used in Pharmaceutical Industry:
Nifenalol is used as a beta-adrenergic antagonist for the treatment of cardiovascular diseases, such as hypertension, angina pectoris, and arrhythmias. Its application in this industry is due to its ability to reduce heart rate, lower blood pressure, and decrease the workload on the heart, thus providing relief from the symptoms of these conditions.
Additionally, nifenalol is used as an αor β-adrenergic blocking agent for developing treatments for cardiac failure, asthma, and glaucoma. The application reason is its effectiveness in managing the symptoms of these conditions by blocking the action of adrenaline and noradrenaline on the respective receptors, leading to improved patient outcomes and quality of life.

Check Digit Verification of cas no

The CAS Registry Mumber 7413-36-7 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 7,4,1 and 3 respectively; the second part has 2 digits, 3 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 7413-36:
(6*7)+(5*4)+(4*1)+(3*3)+(2*3)+(1*6)=87
87 % 10 = 7
So 7413-36-7 is a valid CAS Registry Number.
InChI:InChI=1/C11H16N2O3/c1-8(2)12-7-11(14)9-3-5-10(6-4-9)13(15)16/h3-6,8,11-12,14H,7H2,1-2H3

7413-36-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 14, 2017

Revision Date: Aug 14, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-(Isopropylamino)-1-(4-nitrophenyl)ethanol

1.2 Other means of identification

Product number -
Other names Methanesulfonamide,N-[4-[(1R)-2-chloro-1-hydroxyethyl]phenyl]

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:7413-36-7 SDS

7413-36-7Relevant articles and documents

Preparing β-blocker (R)-Nifenalol based on enantioconvergent synthesis of (R)-p-nitrophenylglycols in continuous packed bed reactor with epoxide hydrolase

Li, Fu-Long,Zheng, Yu-Cong,Li, Hao,Chen, Fei-Fei,Yu, Hui-Lei,Xu, Jian-He

, p. 1706 - 1710 (2019/01/30)

An engineered epoxide hydrolase from Vigna radiate (VrEH2M263N) shows near-perfect enantioconvergence in single enzyme mediated hydrolysis of racemic p-nitrostyrene oxide (pNSO). To explore industrial potential of the promising biocatalyst, we tried to immobilize the VrEH2 variant by covalently linking onto a commercially available amino resin ECR8405F. Then a 5-mL packed bed reactor filled with the immobilized VrEH2M263N was connected with macroporous resin NKA-11 for in situ product adsorption, and the product (R)-p-nitrophenyl glycol (pNPG) was harvested by methanol elution, with 91% isolated yield and 97% ee. The continuous reactor was operated stably for more than 100 h with a space time yield of 20 g?L?1?h?1. Subsequently, the β-blocker (R)-Nifenalol was prepared by chemically synthesized from (R)-pNPG, affording the product in an overall yield of 61.3% (1.5 g) and an enantiopurity of 99.9% ee after recrystallization.

Effect of basic and acidic additives on the separation of some basic drug enantiomers on polysaccharide-based chiral columns with acetonitrile as mobile phase

Gogaladze, Khatuna,Chankvetadze, Lali,Tsintsadze, Maia,Farkas, Tivadar,Chankvetadze, Bezhan

, p. 228 - 234 (2015/03/18)

The separation of enantiomers of 16 basic drugs was studied using polysaccharide-based chiral selectors and acetonitrile as mobile phase with emphasis on the role of basic and acidic additives on the separation and elution order of enantiomers. Out of the studied chiral selectors, amylose phenylcarbamate-based ones more often showed a chiral recognition ability compared to cellulose phenylcarbamate derivatives. An interesting effect was observed with formic acid as additive on enantiomer resolution and enantiomer elution order for some basic drugs. Thus, for instance, the enantioseparation of several β-blockers (atenolol, sotalol, toliprolol) improved not only by the addition of a more conventional basic additive to the mobile phase, but also by the addition of an acidic additive. Moreover, an opposite elution order of enantiomers was observed depending on the nature of the additive (basic or acidic) in the mobile phase.

One-pot route to β-adrenergic blockers via enantioselective organocatalysed epoxidation of terminal alkenes as a key step

Held, Felix E.,Wei, Shengwei,Eder, Kathrin,Tsogoeva, Svetlana B.

, p. 32796 - 32801 (2014/08/18)

A convenient and environmentally attractive one-pot two-step process for the synthesis of β-adrenergic blockers via Shi's organocatalytic epoxidation of terminal alkenes and subsequent aminolysis reaction of epoxides with isopropylamine under mild reaction conditions has been developed. This journal is the Partner Organisations 2014.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 7413-36-7